DaVita Inc. (DVA) — Fair Value Analysis

Base-case fair value (P50): $279.77 · Current price: $195.96 · Verdict: Undervalued

The Verdict on DVA

DaVita (DVA), a key player in the Healthcare sector, is currently undervalued based on our comprehensive Monte Carlo simulations. With the stock trading at $195.96, our analysis indicates a median fair value (P50) of $279.77. This presents a substantial potential +42.8% from its current market price. Our models, simulating thousands of forward scenarios, consistently point to DVA trading below its intrinsic value. This disparity suggests the market is not fully appreciating the company's underlying fundamentals relative to its future earnings potential, despite its current market valuation.

How DVA stacks up against Healthcare

DVA's operational and financial health is categorized as average when compared to its peers within the broader Healthcare sector. This quality tier is a critical input in our Monte Carlo simulations, influencing the range and probability distribution of its fair value. Despite an average quality profile, the significant gap between $195.96 and the calculated $279.77 highlights an attractive opportunity. The current market price does not fully reflect the potential for DVA to reach its median intrinsic value, even within the context of its sector standing. This suggests that the market might be overlooking aspects of DVA's stability or future cash flow generation, leading to its undervalued status.

What this means for investors

Investors monitoring the Healthcare sector should note DVA's undervalued status and the projected +42.8% to its median fair value of $279.77. The Monte Carlo framework provides a robust assessment, moving beyond single-point estimates by modeling diverse future market and operational conditions to determine a probabilistic range of fair values. While the market currently prices DVA at $195.96, the simulations suggest a strong potential for price appreciation. For those seeking deeper insights into DVA's bear and bull case scenarios, a free FairCurve account offers the full distribution and helps track DVA's fair value as new fundamentals are released.